Pixium Vision S.A.

One must remember the notion that restoring some visual perception to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the New Age of enabling bionic visual perception for patients blind from retinal dystrophies (retinitis pigmentosa, choroideremia, cone-rod dystrophy, usher syndrome, dry-AMD) leaving them with bare light or no light perception. Pixium Vision develops innovative Retinal Bionic Vision Systems, which incorporate active implantable prostheses intended to treat and compensate for blindness resulting from the degeneration of retinal photoreceptor cells, These devices are intended for blind people with a functional optic nerve to enable them to regain greater autonomy and improved quality of daily living. The Company harnesses the rapid advances in neuroscience, visual processing, microelectronics / nanoelectronics, optoelectronics, neurobiology and intelligent software algorithms. Pixium Vision was created in December 2011 incorporating the global expertise, knowhow and technologies via a global ecosystem of several renowned scientists from prestigious academic and technology institutions worldwide. The fast evolving bionic retinal implant technologies continue to build evidence of longer term functional vision and visual function. Imagine better is possible !